Latest News about RHHBY
Recent news which mentions RHHBY
Opthea Outlines OPT-302 Pivotal Study Designs In Chronic Eye Disorder
February 24, 2021
From Benzinga
Why Turning Point Is Turning Heads
February 23, 2021
From Motley Fool
2 Best Pharma Stocks to Buy Right Now
February 23, 2021
From Motley Fool
Your 2 Best Profit Opportunities in 2021
February 20, 2021
From Motley Fool
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
From Benzinga
Roche's Faricimab On Par With Rival Regeneron's Aflibercept In Four Late-Stage Studies In Vision Loss Disorder
February 12, 2021
From Benzinga
How ImmunoGen Trounced Analysts' Q4 Revenue and Earnings Estimates
February 12, 2021
From Motley Fool
GenMark Surges On Report Of Potential Takeover Amid Interest From Buyers: Bloomberg
February 11, 2021
From Benzinga
Why GenMark Diagnostics Stock Is Soaring Today
February 11, 2021
From Motley Fool
Oxford Researchers Say Roche's Arthritis Drug Cuts Death In Hospitalized COVID-19 Patients
February 11, 2021
From Benzinga
How Is OTC Markets Different From Exchanges?
February 10, 2021
From Benzinga
How The Major Indexes On OTC Markets Performed In 2020
February 09, 2021
From Benzinga
Roche Unit Spark Therapeutics' Hemophilia A Gene Therapy Shows Durable Benefit In Early-Stage Study
February 05, 2021
From Benzinga
COVID-19 Test Business Fuels Roche Q4 Sales, Hikes Dividend
February 04, 2021
From Benzinga
The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs
February 04, 2021
From Benzinga
Affimed Partners With Roche To Develop AFM24 Combo Therapy In EGFR Expressing Solid Tumors
February 03, 2021
From Benzinga
The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision
February 03, 2021
From Benzinga
These 2 Coronavirus Stocks Could Soar in the First Half of 2021
January 26, 2021
From Motley Fool
Why MacroGenics Stock Jumped Today
January 25, 2021
From Motley Fool
The Most Actively Traded Securities On OTC Markets In 2020 Included Cannabis, Crypto, And Multinationals
January 25, 2021
From Benzinga
3 Blockbuster Drug Launches to Watch This Year
January 24, 2021
From Motley Fool
If You Invested $10,000 in Personalis in the Coronavirus Crash, This Is How Much You'd Have Now
January 23, 2021
From Motley Fool
Why BioNTech's Multiple Sclerosis Vaccine Could Be a Game Changer
January 23, 2021
From Motley Fool
From Benzinga
Can Clover Health Fix Medicare's Problems?
January 21, 2021
From Motley Fool
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
January 14, 2021
From Motley Fool
7 Great Index Funds To Buy With Super Low Fees
January 14, 2021
From InvestorPlace
Regeneron To Supply US With Another 1.25M COVID-19 Treatment Doses
January 13, 2021
From Benzinga
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
Here's Why Sarepta Therapeutics Lost Support on Wall Street
January 10, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.